Notice: Images are for illustration only and may not reflect the exact product you receive. Brand-name medications may look different depending on their country of origin—Canadian versions, for example, often include a "PR" symbol on the packaging. Rest assured, the medication, dosage, and active ingredients will be exactly as prescribed. Canada Pharmacy Store is committed to your health and safety, and we work only with licensed pharmacies to ensure you receive trusted, high-quality medication every time.
General Medication Fact Sheet for Tanzeum
| Field | Information |
|---|---|
| Medication Name | Tanzeum |
| Generic Name | Albiglutide |
| Boxed/Label Warning | May cause thyroid C-cell tumors, including medullary thyroid carcinoma (MTC). Avoid in patients with a personal or family history of MTC or in patients with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). |
| Purpose | Treatment of type 2 diabetes mellitus, along with diet and exercise, to improve glycemic control. |
| Mechanism of Action | Glucagon-like peptide-1 (GLP-1) receptor agonist; enhances glucose-dependent insulin secretion and slows gastric emptying. |
| Dosage Forms | Subcutaneous injection |
| Available Strengths | 30 mg/0.5 mL, 50 mg/0.5 mL |
| Dosage Frequency | Once weekly |
| Common Side Effects | Nausea, diarrhea, constipation, injection site reactions, upper respiratory tract infection. |
| Serious Side Effects | Pancreatitis, gallbladder disease, kidney problems, severe allergic reactions, thyroid tumors. |
| Drug Interactions | Insulin secretagogues (e.g., sulfonylureas), insulin, medications that affect gastric emptying. |
| Important Notes | Monitor for signs and symptoms of pancreatitis and gallbladder disease. Educate patients about the risk of thyroid tumors. Use with caution in patients with renal impairment. |
| Storage | Store refrigerated at 36°F to 46°F (2°C to 8°C) until time of use. Do not freeze. Protect from light. |
| Missed Dose | Administer the missed dose as soon as possible within 3 days of the missed dose. If more than 3 days have passed, skip the missed dose and administer the next dose on the regularly scheduled day. |
| Alternatives | Ozempic (semaglutide), Trulicity (dulaglutide), Mounjaro (tirzepatide), Victoza (liraglutide) |
Tanzeum Alternatives
| Medication | Mechanism of Action | Notes |
|---|---|---|
| Ozempic (semaglutide) | GLP-1 receptor agonist | Administered once weekly as a subcutaneous injection. May also promote weight loss. |
| Trulicity (dulaglutide) | GLP-1 receptor agonist | Administered once weekly as a subcutaneous injection. |
| Mounjaro (tirzepatide) | GIP and GLP-1 receptor agonist | Administered once weekly as a subcutaneous injection; dual mechanism of action. |
| Victoza (liraglutide) | GLP-1 receptor agonist | Administered once daily as a subcutaneous injection. |
Tanzeum Side Effects
| Common Side Effects | Serious Side Effects |
|---|---|
| Nausea | Pancreatitis |
| Diarrhea | Gallbladder disease |
| Constipation | Kidney problems |
| Injection site reactions | Severe allergic reactions (anaphylaxis, angioedema) |
| Upper respiratory tract infection | Thyroid tumors (including medullary thyroid carcinoma) |
Tanzeum Dosage Guide
| Condition | Starting Dose | Maintenance Dose | Administration Notes |
|---|---|---|---|
| Type 2 Diabetes Mellitus | 30 mg once weekly | May be increased to 50 mg once weekly based on glycemic control | Administer subcutaneously in the thigh, abdomen, or upper arm. Rotate injection sites. |
Tanzeum Price With And Without Insurance
| Purchase Context | Estimated Price |
|---|---|
| With Insurance | $50 |
| Without Insurance (U.S.) | $1100 |
| From Canada | $600 |
